Skip to main content
Joseph Han, MD, Otolaryngology (ENT), Norfolk, VA

JosephKhristianHanMD

Otolaryngology (ENT) Norfolk, VA

Rhinology & Paranasal Sinus Disease

Professor of Otolaryngology, Eastern Virginia Medical School

Dr. Han is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Han's full profile

Already have an account?

  • Office

    600 Gresham Dr
    Suite 1100
    Norfolk, VA 23507
    Phone+1 757-388-6200
    Fax+1 757-388-6201

Education & Training

  • Medical College of Wisconsin Affiliated Hospitals
    Medical College of Wisconsin Affiliated HospitalsResidency, Otolaryngology - Head and Neck Surgery, 1998 - 2002
  • MCP-Hahnemann College of Medicine
    MCP-Hahnemann College of MedicineClass of 1997

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2002 - Present
  • VA State Medical License
    VA State Medical License 2003 - 2026
  • WI State Medical License
    WI State Medical License 1998 - 2003
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Most Compassionate Doctor American Registry
  • Super Doctor SuperDoctors.com
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • AstraZeneca Plc Tezspire Meets Primary Endpoints in WAYPOINT Trial
    AstraZeneca Plc Tezspire Meets Primary Endpoints in WAYPOINT TrialNovember 8th, 2024
  • TEZSPIRE Met Both Co-Primary Endpoints in the Phase III WAYPOINT Trial in Patients with Chronic Rhinosinusitis with Nasal Polyps
    TEZSPIRE Met Both Co-Primary Endpoints in the Phase III WAYPOINT Trial in Patients with Chronic Rhinosinusitis with Nasal PolypsNovember 8th, 2024
  • New 12-Month Results from the VATRAC Trial Confirm Durable Efficacy of Aerin Medical’s VivAer® in Patients with Nasal Valve Collapse
    New 12-Month Results from the VATRAC Trial Confirm Durable Efficacy of Aerin Medical’s VivAer® in Patients with Nasal Valve CollapseSeptember 6th, 2022
  • Join now to see all

Committees

  • Member, Guideline Development Panel, American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF) 2015 - Present

Professional Memberships